JAMA Medical News cover image

Highlights From the American Diabetes Association Scientific Session 2023

JAMA Medical News

00:00

The Effect of Samagletide on Weight Loss

Samagletide has been in the news quite a lot. It's an oral version of ribelces, which is approved for type 2 diabetes. A new study looked at a higher dose for weight loss in people without diabetes. Having an orally available version of this treatment can make a big difference and reach many more people.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app